VHH

Publish with a VHH developed by Covalab...

Podium

Offer valid for the first 3 laboratories publishing an article with a VHH developed by Covalab, limited to one reimbursement by laboratory and by publication. The 1st laboratory may ask the reimbursement of a congress registrationup to 500€, the 2nd one up to 300€, and 200€ for the 3rd one. The reimbursement for congress fees will be done on thebasis of its invoice. Offer subject to purchasing conditions of VHH development service before the 12/31/2020.

VHH fragments of only 15 kDa come from camelids IgG2 and IgG3. Being more stable and soluble than conventional IgG they allow to reach hardly accessible antigens and penetrate tissues easier. Moreover they can be produced in high scale to enhance your research.

... We reimburse your pass for the congress of your choice.